James Welch
Keine laufenden Positionen mehr
Profil
James H.
Welch worked as a Chief Financial Officer and Secretary at various pharmaceutical companies such as Rigel Pharmaceuticals, Cerimon Pharmaceuticals, and Virobay, Inc. He also worked as a Principal at Avantek, Inc. and as a Division Controller at NeXT Software, Inc. Welch was the Chief Financial Officer and Head-Investor Relations at Talphera, Inc. and Eiger BioPharmaceuticals, Inc. He holds a Master's in Business Administration from Washington State University and an undergraduate degree from Whitworth University.
Ehemalige bekannte Positionen von James Welch
Unternehmen | Position | Ende |
---|---|---|
CHINOOK THERAPEUTICS, INC. | Finanzdirektor/CFO | 30.10.2019 |
EIGER BIOPHARMACEUTICALS, INC. | Finanzdirektor/CFO | 03.12.2018 |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Finanzdirektor/CFO | 01.01.2015 |
TALPHERA, INC. | Finanzdirektor/CFO | 25.03.2014 |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Finanzdirektor/CFO | 01.09.2010 |
Ausbildung von James Welch
Whitworth University | Undergraduate Degree |
Washington State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
TALPHERA, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
NeXT Software, Inc.
NeXT Software, Inc. Packaged SoftwareTechnology Services NeXT Software, Inc. develops software. The company is based in Redwood City, CA. The company was founded by Steven Jobs. NeXT Software was acquired by Apple, Inc. on February 07, 1997. | Technology Services |
Beluga Composites Corp.
Beluga Composites Corp. Medical SpecialtiesHealth Technology Beluga Composites Corp. develops and manufactures immunodiagnostic testing systems and related therapeutic drug monitoring systems. The firm's products include single water tanks, double water tanks, container series tanks, compartment tanks and accessories. The company is headquartered in Montreal, Canada. | Health Technology |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Virobay, Inc. develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases. It utilize cysteine cathepsin platform for the development and commercialization of novel drugs. The firm's research & development activities focuses on neuropathic pain, autoimmune diseases and liver fibrosis. The company was founded by Robert F. G. Booth on May 18, 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Avantek, Inc.
Avantek, Inc. SemiconductorsElectronic Technology Avantek, Inc. is an American company that specializes in creating innovative home decor solutions. The private company's flagship product, the Ferrous Wall, allows users to modernize their rooms to a futuristic level by eliminating the need for nails or screws to attach shelves and cabinets. This gives users complete freedom to move around shelves and picture frames. Additionally, Avantek has created the world's first retractable magnetic hinge, which uses magnetic force that can be turned on and off with the click of a button. | Electronic Technology |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |